Skip to main navigation Skip to search Skip to main content

Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3, 5-dione: A novel agonist 5-HT1A receptor PET ligand

  • Jaya Prabhakaran
  • , Ramin V. Parsey
  • , Vattoly J. Majo
  • , Shu Chi Hsiung
  • , Matthew S. Milak
  • , Hadassah Tamir
  • , Norman R. Simpson
  • , Ronald L. Van Heertum
  • , J. John Mann
  • , J. S. Dileep Kumar

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Synthesis and in vivo evaluation of 2-{4-[4-(3-methoxyphenyl)piperazin-1- yl]-butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione (5 or MMT), a high affinity and selective serotonin 5-HT1AR agonist PET tracer, are described. GTPγS assay shows that MMT is an agonist with an EC50 comparable to 5-HT. Radiolabeling of 5 was achieved in 30% yield (EOS) from desmethyl-MMT (4) with >99% chemical and radiochemical purities and a specific activity >1000 Ci/mmol. PET studies in baboon show that [ 11C]5 penetrates the blood-brain barrier but, because of low specific binding and fast clearance of radioactivity it is not a suitable PET tracer for the in vivo quantification of 5-HT1AR.

Original languageEnglish
Pages (from-to)2101-2104
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume16
Issue number8
DOIs
StatePublished - Apr 15 2006

Keywords

  • Agonism
  • Positron emission tomography
  • Radiotracer
  • [C]MMT

Fingerprint

Dive into the research topics of 'Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3, 5-dione: A novel agonist 5-HT1A receptor PET ligand'. Together they form a unique fingerprint.

Cite this